URL has been copied successfully!
bioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading lower Monday morning. The move follows a massive surge during Friday’s session. Traders appear to be taking profits after the stock skyrocketed over 120% to end the week.
Friday Rally Driven By CyPath Growth
The clinical stage diagnostics company saw heavy buying interest on Friday as the stock soared on strong growth in its flagship CyPath Lung diagnostic.
The company reported that CyPath Lung revenue rose 87% year-over-year in 2025. Furthermore, the number of tests performed jumped 99%.
Despite the success of CyPath, total 2025 revenue fell to $6.2 million from $9.4 million. …
Please follow us:
This post was originally published here
